Glovax to start P7.5bn vaccine plant operations in October 2022
The Department of Trade and Industry (DTI) and Glovax Biotech Corp. signed a memorandum of agreement with the Department of Trade and Industry (DTI) regarding the P7.5 billion-COVID-19 vaccine plant project in the country.
Glovax is looking to start the facility operations in October 2022. It will fill vials with COVID-19 vaccines developed by its South Korean technology partner EuBiologics Co. Ltd.
The Anti-Red Tape Authority, Department of Health, Food and Drug Administration, Department of Trade and Industry-Board of Investments, Department of Science and Technology, and National Task Force Against COVID-19 has recently signed a joint memorandum circular providing a green lane for COVID-19 manufacturers in the country.
United Laboratories Inc., IG/IP Biotech and Dr. Zen Biotech has previously expressed interest in putting up vaccine manufacturing plants in the country.
Related news
- New BPO firm said to be looking to employ 1,000 nurses in Iloilo City · 16 Oct 2019
- 542 Illegal overseas workers arrested in raid on Pasay City BPO 0peration · 14 Oct 2019
- Calabrio’s self-scheduling software aims to enhance contact center oversight · 14 Oct 2019
Disclosure: Outsource Accelerator uses AI tools in the backend of its editorial workflow. Every article is reviewed and verified by a human editor before publication.
Stay ahead of the outsourcing industry. Join thousands of business leaders who rely on Outsource Accelerator for the news, trends, and expert insights that matter. Subscribe to our free newsletter and never miss an update.
